When a patient presents with epididymo-orchitis and Mycoplasma genitalium has been confirmed on microbiological testing, the identified organism should directly guide management. This is a distinct clinical situation from cases where no pathogen is confirmed.
Epididymo-orchitis in the context of a positive Mycoplasma genitalium result. Knowing the causative organism allows treatment to be directed specifically toward that pathogen, rather than relying on empirical cover alone.
When M. genitalium is identified, an appropriate antibiotic active against this organism is included in the treatment plan, alongside general supportive measures. The complete regimen — antibiotic selection, duration, and full supportive care — is set out in the structured protocol.
The primary indicator of response is improvement in symptoms at three days. If improvement is not seen at that point, clinical review and reassessment of the diagnosis are indicated.
DOI: 10.1177/0956462417699356
Where M. genitalium testing has been performed, and the organism identified, treatment should be guided to include an appropriate antibiotic (e.g. moxifloxacin 400 mg once daily for 14 days) IVC.
General advice: analgesia, rest and scrotal support;
At three days if there is no improvement in symptoms, the patient should be seen for clinical review and the diagnosis should be reassessed.
View source ↗